Phio Pharmaceuticals Corp. (PHIO) DCF Valuation

Phio Pharmaceuticals Corp. (PHIO) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Phio Pharmaceuticals Corp. (PHIO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Phio Pharmaceuticals Corp. (PHIO) with our advanced DCF Calculator! Adjust critical assumptions, explore various scenarios, and evaluate the effects of changes on Phio Pharmaceuticals Corp. (PHIO) valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -100 0 0 0 -25 -25 -25 -25 -25
EBITDA -8.9 -8.7 -13.1 -11.3 -10.6 .0 .0 .0 .0 .0
EBITDA, % -42476.19 100 100 100 100 60 60 60 60 60
Depreciation .1 .2 .2 .2 .2 .0 .0 .0 .0 .0
Depreciation, % 319.05 100 100 100 100 100 100 100 100 100
EBIT -9.0 -8.9 -13.3 -11.5 -10.8 .0 .0 .0 .0 .0
EBIT, % -42795.24 100 100 100 100 60 60 60 60 60
Total Cash 6.9 14.2 24.1 11.8 8.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 0 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 100 100 100 100 80 80 80 80 80
Accounts Payable .8 .7 .3 .8 .7 .0 .0 .0 .0 .0
Accounts Payable, % 3852.38 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 .0 -.1 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -342.86 100 100 100 100 -20 -20 -20 -20 -20
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -8.9 -8.9 -13.2 -11.3 -10.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -8.1 -8.8 -13.5 -10.7 -10.8 -.7 .0 .0 .0 .0
WACC, % 10.86 10.86 10.86 10.86 10.86 10.86 10.86 10.86 10.86 10.86
PV UFCF
SUM PV UFCF -.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -8
Equity Value 8
Diluted Shares Outstanding, MM 0
Equity Value Per Share 33.96

What You Will Get

  • Real PHIO Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Phio Pharmaceuticals' future performance.
  • User-Friendly Design: Designed for professionals while remaining accessible to newcomers.

Key Features

  • 🔍 Real-Life PHIO Financials: Pre-filled historical and projected data for Phio Pharmaceuticals Corp.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Phio’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Phio’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based PHIO DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically computes Phio Pharmaceuticals' intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation fluctuations.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.

Why Choose Phio Pharmaceuticals Corp. (PHIO)?

  • Innovative Solutions: Cutting-edge therapies designed to address unmet medical needs.
  • Scientific Expertise: Backed by a team of experienced professionals in the pharmaceutical field.
  • Robust Pipeline: A diverse range of product candidates in various stages of development.
  • Commitment to Quality: Adherence to the highest standards in research and manufacturing processes.
  • Proven Track Record: Recognized for delivering results and advancing healthcare solutions.

Who Should Use This Product?

  • Investors: Evaluate Phio Pharmaceuticals Corp. (PHIO) to inform stock trading decisions.
  • CFOs and Financial Analysts: Optimize valuation methods and validate financial projections.
  • Startup Founders: Understand the valuation strategies of established biotech companies like Phio Pharmaceuticals.
  • Consultants: Create detailed valuation reports for clients in the pharmaceutical sector.
  • Students and Educators: Utilize current data to study and teach valuation practices in the biotech industry.

What the Template Contains

  • Preloaded PHIO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.